Company intelligence / Profile preview
Chengdu Qingshan Likang Pharmaceutical
Chengdu, Sichuan, Chinaqslk.net ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has over 50 commercialized products including blood purification solutions, large volume injections (>2000 mL), Class III medical devices, traditional Chinese medicine soft capsules, anti-infection eye drops, and proprietary biofilm technology. It also possesses exclusive technology for decellularized amniotic membranes. At least two clinical trials are associated with the company as of March 2025. No detailed results from these trials are publicly available.
- Therapeutic areas
- Infectious DiseasesOphthalmologyGastroenterologyOtherNephrology
- Modalities
- Small moleculeBiologicMedical device
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Chengdu Qingshan Likang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chengdu Qingshan Likang Pharmaceutical.